Literature DB >> 24365115

Modern chromatographic and mass spectrometric techniques for protein biopharmaceutical characterization.

Koen Sandra1, Isabel Vandenheede2, Pat Sandra2.   

Abstract

Protein biopharmaceuticals such as monoclonal antibodies and therapeutic proteins are currently in widespread use for the treatment of various life-threatening diseases including cancer, autoimmune disorders, diabetes and anemia. The complexity of protein therapeutics is far exceeding that of small molecule drugs; hence, unraveling this complexity represents an analytical challenge. The current review provides the reader with state-of-the-art chromatographic and mass spectrometric tools available to dissect primary and higher order structures, post-translational modifications, purity and impurity profiles and pharmacokinetic properties of protein therapeutics.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biopharmaceutical; Chromatography; Mass spectrometry; Monoclonal antibody; Therapeutic protein

Mesh:

Substances:

Year:  2013        PMID: 24365115     DOI: 10.1016/j.chroma.2013.11.057

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  17 in total

1.  Development of a quantitative mass spectrometry multi-attribute method for characterization, quality control testing and disposition of biologics.

Authors:  Richard S Rogers; Nancy S Nightlinger; Brittney Livingston; Phil Campbell; Robert Bailey; Alain Balland
Journal:  MAbs       Date:  2015-07-17       Impact factor: 5.857

2.  Mass Spectrometry Based Mechanistic Insights into Formation of Tris Conjugates: Implications on Protein Biopharmaceutics.

Authors:  Pradeep G Kabadi; Praveen Kallamvalliillam Sankaran; Dinesh V Palanivelu; Laxmi Adhikary; Anand Khedkar; Amarnath Chatterjee
Journal:  J Am Soc Mass Spectrom       Date:  2016-08-03       Impact factor: 3.109

3.  Comparison of originator and biosimilar monoclonal antibodies using HRMS, Fc affinity chromatography, and 2D-HPLC.

Authors:  Lars M H Reinders; Martin D Klassen; Thorsten Teutenberg; Martin Jaeger; Torsten C Schmidt
Journal:  Anal Bioanal Chem       Date:  2022-07-27       Impact factor: 4.478

Review 4.  High-Resolution Native Mass Spectrometry.

Authors:  Sem Tamara; Maurits A den Boer; Albert J R Heck
Journal:  Chem Rev       Date:  2021-08-20       Impact factor: 72.087

5.  Rational design, preparation and characterization of recombinant Ag85B variants and their glycoconjugates with T-cell antigenic activity against Mycobacterium tuberculosis.

Authors:  Francesca Rinaldi; Sara Tengattini; Luciano Piubelli; Roberta Bernardini; Francesca Mangione; Teodora Bavaro; Gregorino Paone; Maurizio Mattei; Loredano Pollegioni; Gaetano Filice; Caterina Temporini; Marco Terreni
Journal:  RSC Adv       Date:  2018-06-26       Impact factor: 4.036

6.  Top-Down Characterization of an Intact Monoclonal Antibody Using Activated Ion Electron Transfer Dissociation.

Authors:  Jean M Lodge; Kevin L Schauer; Dain R Brademan; Nicholas M Riley; Evgenia Shishkova; Michael S Westphall; Joshua J Coon
Journal:  Anal Chem       Date:  2020-07-16       Impact factor: 6.986

7.  Statistical characterization of therapeutic protein modifications.

Authors:  Tsung-Heng Tsai; Zhiqi Hao; Qiuting Hong; Benjamin Moore; Cinzia Stella; Jeffrey H Zhang; Yan Chen; Michael Kim; Theo Koulis; Gregory A Ryslik; Erik Verschueren; Fred Jacobson; William E Haskins; Olga Vitek
Journal:  Sci Rep       Date:  2017-08-11       Impact factor: 4.379

8.  At-Line Reversed Phase Liquid Chromatography for In-Process Monitoring of Inclusion Body Solubilization.

Authors:  Julian Ebner; Diana Humer; Robert Klausser; Viktor Rubus; Reinhard Pell; Oliver Spadiut; Julian Kopp
Journal:  Bioengineering (Basel)       Date:  2021-06-07

9.  Monitoring antigenic protein integrity during glycoconjugate vaccine synthesis using capillary electrophoresis-mass spectrometry.

Authors:  Sara Tengattini; Elena Domínguez-Vega; Caterina Temporini; Marco Terreni; Govert W Somsen
Journal:  Anal Bioanal Chem       Date:  2016-07-02       Impact factor: 4.142

10.  Native mass spectrometry combined with enzymatic dissection unravels glycoform heterogeneity of biopharmaceuticals.

Authors:  Therese Wohlschlager; Kai Scheffler; Ines C Forstenlehner; Wolfgang Skala; Stefan Senn; Eugen Damoc; Johann Holzmann; Christian G Huber
Journal:  Nat Commun       Date:  2018-04-30       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.